Literature DB >> 28252198

Cre-loxP-Mediated Recombination: General Principles and Experimental Considerations.

Micheal A McLellan1,2, Nadia A Rosenthal1,3,4, Alexander R Pinto1,3.   

Abstract

The cre-loxP-mediated recombination system (the "cre-loxP system") is an integral experimental tool for mammalian genetics and cell biology. Use of the system has greatly expanded our ability to precisely interrogate gene function in the mouse, providing both spatial and temporal control of gene expression. This has been largely due to the simplicity of its use and its adaptability to address diverse biological questions. While the use of the cre-loxP system is becoming increasingly widespread, in particular because of growing availability of conditional mouse mutants, many considerations need to be taken into account when utilizing the cre-loxP system. This review provides an overview of the cre-loxP system and its various permutations. It addresses the limitations of cre-loxP technology and related considerations for experimental design, and it discusses alternative strategies for site-specific genetic recombination and integration. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  conditional genetics; cre; cre-loxP; gene editing; loxP; recombination; site directed mutagenesis

Mesh:

Substances:

Year:  2017        PMID: 28252198     DOI: 10.1002/cpmo.22

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN: 2161-2617


  34 in total

Review 1.  The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes.

Authors:  Javier Fernández-Ruiz
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

Review 2.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

3.  Rapid and efficient in vitro excision of BAC sequences from herpesvirus genomes using Cre-mediated recombination.

Authors:  Peter Grzesik; Nathan Ko; Lauren M Oldfield; Sanjay Vashee; Prashant J Desai
Journal:  J Virol Methods       Date:  2018-08-06       Impact factor: 2.014

4.  Generation and characterization of a conditional allele of Interferon Regulatory Factor 6.

Authors:  Arianna L Smith; Youssef A Kousa; Akira Kinoshita; Kate Fodor; Baoli Yang; Brian C Schutte
Journal:  Genesis       Date:  2017-06-22       Impact factor: 2.487

Review 5.  The duality of human oncoproteins: drivers of cancer and congenital disorders.

Authors:  Pau Castel; Katherine A Rauen; Frank McCormick
Journal:  Nat Rev Cancer       Date:  2020-04-27       Impact factor: 60.716

6.  Retrospective Study of Intercalated Disk Defects Associated with Dilated Cardiomyopathy, Atrial Thrombosis, and Heart Failure in BALB/c Mice Deficient in IL4 Receptor α.

Authors:  Alfonso S Gozalo; Patricia M Zerfas; William R Elkins; Richard L Gieseck
Journal:  Comp Med       Date:  2020-05-08       Impact factor: 0.982

7.  Cartilage-Specific Cre Recombinase Transgenes/Alleles in the Mouse.

Authors:  Ioannis Kanakis; Mohammad Alhashmi; Ke Liu; Craig Keenan; Lorenzo Ramos Mucci; Blandine Poulet; George Bou-Gharios
Journal:  Methods Mol Biol       Date:  2021

8.  Advances in optogenetic regulation of gene expression in mammalian cells using cryptochrome 2 (CRY2).

Authors:  Carmen N Hernández-Candia; Christina L Wysoczynski; Chandra L Tucker
Journal:  Methods       Date:  2019-03-21       Impact factor: 3.608

Review 9.  Developmental Pathways of Cardiac Fibroblasts.

Authors:  Michelle D Tallquist
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

10.  Retina-specific targeting of pericytes reveals structural diversity and enables control of capillary blood flow.

Authors:  Elena Ivanova; Carlo Corona; Cyril G Eleftheriou; Paola Bianchimano; Botir T Sagdullaev
Journal:  J Comp Neurol       Date:  2020-09-10       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.